Home/Filings/4/0000899243-21-048359
4//SEC Filing

Dananberg Jamie 4

Accession 0000899243-21-048359

CIK 0001463361other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:26 PM ET

Size

5.1 KB

Accession

0000899243-21-048359

Insider Transaction Report

Form 4
Period: 2021-12-14
Dananberg Jamie
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock, $0.0001 par value

    2021-12-14$1.63/sh10,614$17,301659,697 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001734424

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:26 PM ET
Size
5.1 KB